Sihuan Pharmaceutical Holdings Group 주식 주식분석 | 주식가격 | 뉴스 | 460.HK | BMG8162K1137 | A1C72G

날짜	Sihuan Pharmaceutical Holdings Group 매출	Sihuan Pharmaceutical Holdings Group EBIT	Sihuan Pharmaceutical Holdings Group 이익
2026e	12.85 조. undefined	9.51 조. undefined	2.41 조. undefined
2025e	2.54 조. undefined	-574.7 백만 undefined	103.12 백만 undefined
2024e	2.17 조. undefined	-766.2 백만 undefined	23.44 백만 undefined
2023	1.86 조. undefined	-140.54 백만 undefined	-54.02 백만 undefined
2022	2.18 조. undefined	-536.03 백만 undefined	-1.91 조. undefined
2021	3.04 조. undefined	676.2 백만 undefined	416.51 백만 undefined
2020	2.46 조. undefined	485.82 백만 undefined	473.38 백만 undefined
2019	2.88 조. undefined	1.39 조. undefined	-2.75 조. undefined
2018	2.92 조. undefined	1.72 조. undefined	1.62 조. undefined
2017	2.75 조. undefined	1.47 조. undefined	1.45 조. undefined
2016	3.19 조. undefined	1.94 조. undefined	1.71 조. undefined
2015	3.17 조. undefined	2.07 조. undefined	2.06 조. undefined
2014	3.08 조. undefined	1.98 조. undefined	1.67 조. undefined
2013	2.59 조. undefined	1.5 조. undefined	1.28 조. undefined
2012	3.04 조. undefined	1.02 조. undefined	904.4 백만 undefined
2011	2.24 조. undefined	997.9 백만 undefined	824 백만 undefined
2010	1.04 조. undefined	615.8 백만 undefined	522.1 백만 undefined
2009	708.9 백만 undefined	415.3 백만 undefined	326.3 백만 undefined
2008	510 백만 undefined	300.5 백만 undefined	237.1 백만 undefined
2007	286.3 백만 undefined	174.6 백만 undefined	179.3 백만 undefined
2006	161.8 백만 undefined	108.9 백만 undefined	90.5 백만 undefined
2005	101.6 백만 undefined	45.8 백만 undefined	38.2 백만 undefined
2004	62 백만 undefined	26 백만 undefined	22.2 백만 undefined

	매출	EBIT	이익
2004	62 백만 CNY	26 백만 CNY	22.2 백만 CNY
2005	101.6 백만 CNY	45.8 백만 CNY	38.2 백만 CNY
2006	161.8 백만 CNY	108.9 백만 CNY	90.5 백만 CNY
2007	286.3 백만 CNY	174.6 백만 CNY	179.3 백만 CNY
2008	510 백만 CNY	300.5 백만 CNY	237.1 백만 CNY
2009	708.9 백만 CNY	415.3 백만 CNY	326.3 백만 CNY
2010	1.04 조. CNY	615.8 백만 CNY	522.1 백만 CNY
2011	2.24 조. CNY	997.9 백만 CNY	824 백만 CNY
2012	3.04 조. CNY	1.02 조. CNY	904.4 백만 CNY
2013	2.59 조. CNY	1.5 조. CNY	1.28 조. CNY
2014	3.08 조. CNY	1.98 조. CNY	1.67 조. CNY
2015	3.17 조. CNY	2.07 조. CNY	2.06 조. CNY
2016	3.19 조. CNY	1.94 조. CNY	1.71 조. CNY
2017	2.75 조. CNY	1.47 조. CNY	1.45 조. CNY
2018	2.92 조. CNY	1.72 조. CNY	1.62 조. CNY
2019	2.88 조. CNY	1.39 조. CNY	-2.75 조. CNY
2020	2.46 조. CNY	485.82 백만 CNY	473.38 백만 CNY
2021	3.04 조. CNY	676.2 백만 CNY	416.51 백만 CNY
2022	2.18 조. CNY	-536.03 백만 CNY	-1.91 조. CNY
2023	1.86 조. CNY	-140.54 백만 CNY	-54.02 백만 CNY
2024e	2.17 조. CNY	-766.2 백만 CNY	23.44 백만 CNY
2025e	2.54 조. CNY	-574.7 백만 CNY	103.12 백만 CNY
2026e	12.85 조. CNY	9.51 조. CNY	2.41 조. CNY

2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0.02	0.02	0.04	0.09	0.18	0.29	0.38	0.64	1.04	1.17	1.6	2.07	2.84	2.15	1.73	2.01	-2.47	0.77	0.49	-2.12
3	3	4	10	14	26	28	36	94	127	134	170	246	274	282	286	348	270	301	361
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-4	-9	7	-42	-3	-66	-57	-284	-379	-130	-165	-443	-791	-329	143	-276	-343	-624	-413	-11
-0	0	0.01	0.02	-0.01	0.01	0.03	-0.01	-0.05	-0.12	0	-0.04	-0.73	-0.08	-0.24	-0.23	3.88	-0.19	0.29	1.82
0	0	0	0	0	0	0	0	0	0	8	5	0	0	0	1	0	0	27	55
0	0	2	12	11	26	53	135	215	237	340	249	646	595	441	504	509	214	203	156
0.02	0.02	0.06	0.08	0.18	0.26	0.39	0.38	0.71	1.05	1.57	1.76	1.57	2.02	1.92	1.79	1.42	0.23	0.67	0.05
-3	-13	-17	-49	-86	-44	-68	-142	-358	-714	-1,080	-493	-517	-279	-428	-282	-589	-580	-725	-593
-11	-17	-39	-49	-155	-115	16	-363	-2,862	-2,764	-491	-1,558	-386	0	-2,097	822	551	-924	-337	-1,661
-0.01	-0	-0.02	0	-0.07	-0.07	0.08	-0.22	-2.5	-2.05	0.59	-1.07	0.13	0.28	-1.67	1.1	1.14	-0.34	0.39	-1.07
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	24	-18	-4	-12	0	0	-11	767	-523	-183	4	0	-3	87	-91	723	290	152
0	0	0	0	0.2	0	0	5.4	-0.04	0	0	0	0	-1.24	-0.25	0	-0.01	0	-0.2	0
0	-0	-0.01	-0	0.19	-0.07	-0.12	5.22	-0.55	0.11	-1.05	-0.44	-0.26	-1.89	-1.4	-0.13	-0.17	0.18	0.75	-0.24
0	-1	-32	15	0	0	0	0	0	4	-2	-59	16	-49	3	20	131	904	860	924
0	0	0	0	0	-60	-120	-173	-502	-662	-522	-243	-279	-607	-1,144	-240	-198	-1,444	-196	-1,315
0	0	0.01	0.02	0.22	0.07	0.28	5.24	-2.7	-1.61	0.03	-0.24	0.92	0.12	-1.58	2.48	1.8	-0.51	1.08	-1.85
11.4	6.5	39.6	26.2	95.8	212.7	316.9	237.2	354	331.5	493.1	1,267.36	1,051.48	1,738.58	1,489.12	1,510.77	827.93	-353.48	-60.29	-547.44
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Sihuan Pharmaceutical Holdings Group 브루토마진	Sihuan Pharmaceutical Holdings Group 이익 마진	Sihuan Pharmaceutical Holdings Group EBIT-마진	Sihuan Pharmaceutical Holdings Group 이익 마진
2026e	69.64 %	73.97 %	18.76 %
2025e	69.64 %	-22.63 %	4.06 %
2024e	69.64 %	-35.28 %	1.08 %
2023	69.64 %	-7.55 %	-2.9 %
2022	68.2 %	-24.58 %	-87.79 %
2021	79.99 %	22.26 %	13.71 %
2020	77.69 %	19.71 %	19.21 %
2019	79.54 %	48.45 %	-95.66 %
2018	81.55 %	59.08 %	55.53 %
2017	72.36 %	53.35 %	52.77 %
2016	68.71 %	60.75 %	53.62 %
2015	70.35 %	65.51 %	65.12 %
2014	68.46 %	64.17 %	54.19 %
2013	56.28 %	57.88 %	49.68 %
2012	75.25 %	33.62 %	29.73 %
2011	76.47 %	44.51 %	36.75 %
2010	71.82 %	59.39 %	50.35 %
2009	72.93 %	58.58 %	46.03 %
2008	73.82 %	58.92 %	46.49 %
2007	78.87 %	60.98 %	62.63 %
2006	77.19 %	67.31 %	55.93 %
2005	54.33 %	45.08 %	37.6 %
2004	57.1 %	41.94 %	35.81 %

	브루토마진	EBIT-마진	이익 마진
2004	57.1 %	41.94 %	35.81 %
2005	54.33 %	45.08 %	37.6 %
2006	77.19 %	67.31 %	55.93 %
2007	78.87 %	60.98 %	62.63 %
2008	73.82 %	58.92 %	46.49 %
2009	72.93 %	58.58 %	46.03 %
2010	71.82 %	59.39 %	50.35 %
2011	76.47 %	44.51 %	36.75 %
2012	75.25 %	33.62 %	29.73 %
2013	56.28 %	57.88 %	49.68 %
2014	68.46 %	64.17 %	54.19 %
2015	70.35 %	65.51 %	65.12 %
2016	68.71 %	60.75 %	53.62 %
2017	72.36 %	53.35 %	52.77 %
2018	81.55 %	59.08 %	55.53 %
2019	79.54 %	48.45 %	-95.66 %
2020	77.69 %	19.71 %	19.21 %
2021	79.99 %	22.26 %	13.71 %
2022	68.2 %	-24.58 %	-87.79 %
2023	69.64 %	-7.55 %	-2.9 %
2024e	69.64 %	-35.28 %	1.08 %
2025e	69.64 %	-22.63 %	4.06 %
2026e	69.64 %	73.97 %	18.76 %

날짜	Sihuan Pharmaceutical Holdings Group 주당 매출	Sihuan Pharmaceutical Holdings Group EBIT 당 주식	Sihuan Pharmaceutical Holdings Group 주당 이익
2026e	1.38 undefined	0 undefined	0.26 undefined
2025e	0.27 undefined	0 undefined	0.01 undefined
2024e	0.23 undefined	0 undefined	0 undefined
2023	0.2 undefined	-0.02 undefined	-0.01 undefined
2022	0.23 undefined	-0.06 undefined	-0.21 undefined
2021	0.32 undefined	0.07 undefined	0.04 undefined
2020	0.26 undefined	0.05 undefined	0.05 undefined
2019	0.3 undefined	0.15 undefined	-0.29 undefined
2018	0.31 undefined	0.18 undefined	0.17 undefined
2017	0.29 undefined	0.15 undefined	0.15 undefined
2016	0.31 undefined	0.19 undefined	0.17 undefined
2015	0.31 undefined	0.2 undefined	0.2 undefined
2014	0.3 undefined	0.19 undefined	0.16 undefined
2013	0.25 undefined	0.14 undefined	0.12 undefined
2012	0.29 undefined	0.1 undefined	0.09 undefined
2011	0.22 undefined	0.1 undefined	0.08 undefined
2010	0.13 undefined	0.08 undefined	0.07 undefined
2009	0.09 undefined	0.06 undefined	0.04 undefined
2008	0.54 undefined	0.32 undefined	0.25 undefined
2007	0.32 undefined	0.19 undefined	0.2 undefined
2006	0.17 undefined	0.12 undefined	0.1 undefined
2005	0.11 undefined	0.05 undefined	0.04 undefined
2004	0.08 undefined	0.03 undefined	0.03 undefined

	주당 매출	EBIT 당 주식	주당 이익
2004	0.08 CNY	0.03 CNY	0.03 CNY
2005	0.11 CNY	0.05 CNY	0.04 CNY
2006	0.17 CNY	0.12 CNY	0.1 CNY
2007	0.32 CNY	0.19 CNY	0.2 CNY
2008	0.54 CNY	0.32 CNY	0.25 CNY
2009	0.09 CNY	0.06 CNY	0.04 CNY
2010	0.13 CNY	0.08 CNY	0.07 CNY
2011	0.22 CNY	0.1 CNY	0.08 CNY
2012	0.29 CNY	0.1 CNY	0.09 CNY
2013	0.25 CNY	0.14 CNY	0.12 CNY
2014	0.3 CNY	0.19 CNY	0.16 CNY
2015	0.31 CNY	0.2 CNY	0.2 CNY
2016	0.31 CNY	0.19 CNY	0.17 CNY
2017	0.29 CNY	0.15 CNY	0.15 CNY
2018	0.31 CNY	0.18 CNY	0.17 CNY
2019	0.3 CNY	0.15 CNY	-0.29 CNY
2020	0.26 CNY	0.05 CNY	0.05 CNY
2021	0.32 CNY	0.07 CNY	0.04 CNY
2022	0.23 CNY	-0.06 CNY	-0.21 CNY
2023	0.2 CNY	-0.02 CNY	-0.01 CNY
2024e	0.23 CNY	0 CNY	0 CNY
2025e	0.27 CNY	0 CNY	0.01 CNY
2026e	1.38 CNY	0 CNY	0.26 CNY

	주식 수량
2004	750 백만 Aktien
2005	940 백만 Aktien
2006	940 백만 Aktien
2007	897.8 백만 Aktien
2008	940 백만 Aktien
2009	7.5 조. Aktien
2010	8.01 조. Aktien
2011	10.36 조. Aktien
2012	10.35 조. Aktien
2013	10.35 조. Aktien
2014	10.36 조. Aktien
2015	10.36 조. Aktien
2016	10.14 조. Aktien
2017	9.48 조. Aktien
2018	9.47 조. Aktien
2019	9.47 조. Aktien
2020	9.47 조. Aktien
2021	9.48 조. Aktien
2022	9.33 조. Aktien
2023	9.3 조. Aktien
2024e	9.3 조. Aktien
2025e	9.3 조. Aktien
2026e	9.3 조. Aktien

날짜	Sihuan Pharmaceutical Holdings Group 배당금
2026e	0.08 undefined
2025e	0.07 undefined
2024e	0.09 undefined
2023	0.07 undefined
2022	0.12 undefined
2021	0.02 undefined
2020	0.15 undefined
2019	0.02 undefined
2018	0.02 undefined
2017	0.08 undefined
2016	0.07 undefined
2015	0.03 undefined
2014	0.02 undefined
2013	0.05 undefined
2012	0.03 undefined
2011	0.01 undefined

	배당금	배당금 (추정)
2004	0 CNY	0 CNY
2005	0 CNY	0 CNY
2006	0 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0.01 CNY	0 CNY
2012	0.03 CNY	0 CNY
2013	0.05 CNY	0 CNY
2014	0.02 CNY	0 CNY
2015	0.03 CNY	0 CNY
2016	0.07 CNY	0 CNY
2017	0.08 CNY	0 CNY
2018	0.02 CNY	0 CNY
2019	0.02 CNY	0 CNY
2020	0.15 CNY	0 CNY
2021	0.02 CNY	0 CNY
2022	0.12 CNY	0 CNY
2023	0.07 CNY	0 CNY
2024e	0 CNY	0.09 CNY
2025e	0 CNY	0.07 CNY
2026e	0 CNY	0.08 CNY

날짜	Sihuan Pharmaceutical Holdings Group 배당률
2026e	114.97 %
2025e	95.12 %
2024e	140.99 %
2023	108.81 %
2022	-56.42 %
2021	35.56 %
2020	278.58 %
2019	-6.81 %
2018	12.28 %
2017	53.66 %
2016	40.96 %
2015	16.58 %
2014	14.57 %
2013	42.08 %
2012	31.11 %
2011	11.88 %
2010	108.81 %
2009	108.81 %
2008	108.81 %
2007	108.81 %
2006	108.81 %
2005	108.81 %
2004	108.81 %

	배당률
2004	108.81 %
2005	108.81 %
2006	108.81 %
2007	108.81 %
2008	108.81 %
2009	108.81 %
2010	108.81 %
2011	11.88 %
2012	31.11 %
2013	42.08 %
2014	14.57 %
2015	16.58 %
2016	40.96 %
2017	53.66 %
2018	12.28 %
2019	-6.81 %
2020	278.58 %
2021	35.56 %
2022	-56.42 %
2023	108.81 %
2024e	140.99 %
2025e	95.12 %
2026e	114.97 %

EPS-예상치	EPS-실제	보고 분기
0.11	0.06 (-42.39 %)	2017 Q4
0.07	0.09 (25.88 %)	2017 Q2
0.09	0.07 (-22.99 %)	2016 Q2
0.09	0.14 (54.02 %)	2015 Q2
0.09	0.08 (-8.69 %)	2014 Q4
0.08	0.08 (-0.99 %)	2014 Q2
0.06	0.06 (7.59 %)	2013 Q2
0.05	0.04 (-17.31 %)	2012 Q4
0.04	0.04 (10.15 %)	2012 Q2
0.05	0.04 (-8.51 %)	2011 Q4
0.03	0.04 (12.65 %)	2011 Q2

%-지분	이름	주식	변경
5.36 %	Network Victory Ltd	497,448,000	0
4.06 %	Victory Faith International Ltd.	377,267,528	0
31.06 %	Proper Process International Ltd.	2,882,469,225	0
2.75 %	Mingyao Capital Ltd.	255,582,886	0
11.86 %	Successmax Global Holdings Ltd.	1,100,884,399	0
1.33 %	The Vanguard Group, Inc.	123,136,630	-1,035,000
0.73 %	Bosera Asset Management Co., Ltd.	67,324,000	16,425,000
0.66 %	BlackRock Institutional Trust Company, N.A.	61,396,000	78,000
0.60 %	GF Fund Management Co., Ltd.	56,020,000	34,504,000
0.60 %	Dimensional Fund Advisors, L.P.	55,777,000	0
0.21 %	China Asset Management Co., Ltd.	19,098,000	10,375,000
0.16 %	Penghua Fund Management Co., Ltd.	15,119,000	-4,171,000
0.15 %	BlackRock Advisors (UK) Limited	13,915,000	67,000
0.12 %	Guo (Weicheng)	11,350,000	0
0.10 %	State Street Global Advisors (US)	9,412,000	-100,000
0.09 %	Che (Fengsheng)	8,123,666	0
0.07 %	Florida State Board of Administration	6,898,100	4,366,676
0.07 %	Dimensional Fund Advisors, Ltd.	6,802,000	0
0.06 %	American Century Investment Management, Inc.	5,451,000	0
0.04 %	China Asset Management (Hong Kong) Limited	3,684,683	-227,000
0.04 %	Nuveen LLC	3,616,000	0
0.04 %	Norges Bank Investment Management (NBIM)	3,285,661	-1,518
0.03 %	Fisher Investments	3,120,800	0
0.03 %	Geode Capital Management, L.L.C.	2,613,000	0
0.02 %	China Southern Asset Management Co. Ltd.	2,306,000	659,000
0.01 %	State Street Global Advisors Ireland Limited	1,112,000	122,000
0.01 %	Sun (Patrick)	1,000,000	0
0.01 %	HSBC Global Asset Management (UK) Limited	850,000	500,000
0.01 %	China Universal Asset Management Co., Ltd.	828,000	272,000
0.01 %	Vident Investment Advisory, LLC	696,000	0
0.01 %	Exchange Traded Concepts, LLC	696,000	0
0.00 %	Parametric Portfolio Associates LLC	454,000	-702,000
0.00 %	Vanguard Global Advisers LLC	366,000	4,000
0.00 %	Ping An Fund Management Company Limited	348,000	82,000
0.00 %	Vanguard Investments Australia Ltd.	288,524	1,109
0.00 %	UBS Asset Management (Switzerland)	232,000	232,000
0.00 %	BlackRock Financial Management, Inc.	186,000	0
0.00 %	E Fund Management Co. Ltd.	147,921	-5,197,079
0.00 %	Storebrand Kapitalforvaltning AS	131,000	0
0.00 %	Northern Trust Investments, Inc.	125,000	0
0.00 %	Avantis Investors	76,000	0
0.00 %	Prudential Capital Group	56,000	0
0.00 %	Hang Seng Investment Management Ltd.	20,000	0
0.00 %	Great Wall Fund Management Co., Ltd.	7	0
0 %	Bruno Walter Finance SA	0	-1,000,000
0 %	VL Asset Management Limited	0	-1,000,000
0 %	Krane Funds Advisors, LLC	0	-21,000
0 %	Tianhong Asset Management Co., Ltd.	0	-709,000
0 %	Huatai-PineBridge Fund Management Co., Ltd.	0	-1,229,000
0 %	Hwabao WP Fund Management Co., Ltd.	0	-1,177,000
0 %	Yinhua Fund Management Co., Ltd.	0	-642,000
0 %	Galaxy Asset Management Co., Ltd.	0	-206,000
0 %	Fullgoal Fund Management Co., Ltd.	0	-721,000
0 %	State Street Global Advisors (UK) Ltd.	0	-1,158,410
0 %	BlackRock Investment Management (Australia) Ltd.	0	-18,000
0 %	GMO UK Limited	0	-278,000
0 %	BlackRock Investment Management (UK) Ltd.	0	-63,000
0 %	UBS Asset Management (UK) Ltd.	0	-232,000
0 %	Jupiter Asset Management Ltd.	0	-10,045,000
0 %	Wellington Management Company, LLP	0	-6,217,900
0 %	Van Eck Associates Corporation	0	-486,560
0 %	Grantham Mayo Van Otterloo & Co LLC	0	-80,000
0 %	Numeric Investors LLC	0	-2,646,332
0 %	California State Teachers Retirement System	0	-9,165,000
0 %	Natixis Investment Managers SA	0	-21,000
0 %	Mercer Global Investments Management Ltd	0	-653,000

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Laboratory Corp	공급업체고객	0,69	0,78	0,46	-0,03	-0,02	0,67
Strides Pharma Science	공급업체고객	0,59	0,82	0,26	0,01	0,88	0,41
Abliva	공급업체고객	0,54	0,81	0,35	0,02	0,82	-0,37
Ardelyx	공급업체고객	-0,14	0,33	-0,13	-0,15	0,84	0,03

What values and corporate philosophy does Sihuan Pharmaceutical Holdings Group represent?

Sihuan Pharmaceutical Holdings Group Ltd represents several core values and a strong corporate philosophy. As a leading pharmaceutical company in China, Sihuan Pharma is committed to delivering high-quality healthcare solutions to improve patients' lives. Their corporate philosophy revolves around innovation, integrity, and dedication. By focusing on research and development, Sihuan Pharma strives to introduce breakthrough drugs and contribute to medical advancements globally. With a customer-centric approach, the company ensures access to affordable medications while maintaining strict quality control standards. Sihuan Pharmaceutical Holdings Group Ltd's dedication to excellence and commitment to improving healthcare exemplify their core values and corporate philosophy.

In which countries and regions is Sihuan Pharmaceutical Holdings Group primarily present?

Sihuan Pharmaceutical Holdings Group Ltd primarily operates in China.

What significant milestones has the company Sihuan Pharmaceutical Holdings Group achieved?

Sihuan Pharmaceutical Holdings Group Ltd, a leading pharmaceutical company, has achieved several significant milestones. The company successfully listed its shares on the Hong Kong Stock Exchange, making it one of the first Chinese pharmaceutical companies to do so. Sihuan Pharmaceutical has established a strong presence in the global market, expanding its network of subsidiaries and joint ventures across multiple countries. The company has made substantial investments in research and development, resulting in the development of innovative drugs and therapies. Sihuan Pharmaceutical has also secured various partnerships and collaborations with renowned international pharmaceutical companies, further enhancing its growth and market position. These achievements highlight the company's commitment to advancing healthcare and delivering innovative pharmaceutical solutions.

What is the history and background of the company Sihuan Pharmaceutical Holdings Group?

Sihuan Pharmaceutical Holdings Group Ltd is a leading pharmaceutical company that specializes in research, development, manufacturing, and marketing of therapeutic drugs. Founded in 2001 and headquartered in Beijing, China, the company has a rich history of providing innovative and high-quality healthcare solutions. With a focus on cardiovascular and cerebrovascular diseases, oncology, and diabetes treatments, Sihuan Pharmaceutical has become a trusted brand both within China and internationally. Through strategic partnerships, advanced technology, and a commitment to excellence, the company continues to make significant contributions to the medical field, improving patient outcomes, and driving growth in the pharmaceutical industry.

Who are the main competitors of Sihuan Pharmaceutical Holdings Group in the market?

The main competitors of Sihuan Pharmaceutical Holdings Group Ltd in the market are other prominent pharmaceutical companies operating in the same sector. Some notable competitors include Jiangsu Hengrui Medicine Co., Ltd., Sino Biopharmaceutical Limited, and Shanghai Pharmaceuticals Holding Co., Ltd. These companies compete with Sihuan Pharmaceutical in terms of research and development, product offerings, market presence, and overall industry reputation. Sihuan Pharmaceutical Holdings Group Ltd faces a competitive landscape as it strives to maintain its position and market share in the pharmaceutical industry.

In which industries is Sihuan Pharmaceutical Holdings Group primarily active?

Sihuan Pharmaceutical Holdings Group Ltd is primarily active in the pharmaceutical industry.

What is the business model of Sihuan Pharmaceutical Holdings Group?

The business model of Sihuan Pharmaceutical Holdings Group Ltd revolves around researching, developing, manufacturing, and commercializing pharmaceutical products. The company focuses on the research and development of innovative drugs, as well as the acquisition and licensing of technologies and intellectual properties. Sihuan Pharmaceutical Group primarily operates in the Chinese pharmaceutical market, offering a diverse range of therapeutic products targeting various diseases and medical conditions. Through its rigorous clinical trials and efficient production processes, the company aims to deliver high-quality medicines to improve patients' lives. Sihuan Pharmaceutical Group's business model highlights its commitment to innovation, quality, and meeting the healthcare needs of the Chinese market.

Sihuan Pharmaceutical Holdings Group 2024의 P/E 비율은 얼마입니까?

Sihuan Pharmaceutical Holdings Group의 P/E 비율은 194.48입니다.

Sihuan Pharmaceutical Holdings Group 2024의 KUV는 얼마입니까?

Sihuan Pharmaceutical Holdings Group의 P/S 비율은 2.1입니다.

Sihuan Pharmaceutical Holdings Group의 AlleAktien 품질 점수는 얼마인가요?

Sihuan Pharmaceutical Holdings Group에 대한 AlleAktien 품질 점수는 1/10입니다.

Sihuan Pharmaceutical Holdings Group 2024의 매출은 얼마인가요?

예상되는 Sihuan Pharmaceutical Holdings Group 매출은 2.17 조. CNY입니다.

Sihuan Pharmaceutical Holdings Group 2024의 이익은 얼마인가요?

예상되는 Sihuan Pharmaceutical Holdings Group 이익은 23.44 백만 CNY입니다.

Sihuan Pharmaceutical Holdings Group은 무엇을 하나요?

Sihuan Pharmaceutical Holdings Group Ltd is a leading Chinese pharmaceutical company based in Beijing. The company's business model includes three main areas: research and development, manufacturing, and marketing.

Sihuan Pharmaceutical Holdings Group 배당금은 얼마입니까?

Sihuan Pharmaceutical Holdings Group은(는) 연간 번의 배당을 통해 0.12 CNY의 배당금을 지급합니다.

Sihuan Pharmaceutical Holdings Group이 얼마나 자주 배당을 지급하나요?

Sihuan Pharmaceutical Holdings Group의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Sihuan Pharmaceutical Holdings Group ISIN이 무엇입니까?

Sihuan Pharmaceutical Holdings Group의 ISIN은 BMG8162K1137입니다.

Sihuan Pharmaceutical Holdings Group WKN은 무엇인가요?

Sihuan Pharmaceutical Holdings Group의 WKN은 A1C72G입니다.

Sihuan Pharmaceutical Holdings Group 티커는 무엇인가요?

Sihuan Pharmaceutical Holdings Group의 티커는 460.HK입니다.

Sihuan Pharmaceutical Holdings Group이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Sihuan Pharmaceutical Holdings Group은(는) 0.07 CNY 의 배당금을 지급했습니다. 이는 약 15.09 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Sihuan Pharmaceutical Holdings Group은(는) 0.07 CNY의 배당금을 지급할 것으로 예상됩니다.

Sihuan Pharmaceutical Holdings Group의 배당 수익률은 얼마입니까?

Sihuan Pharmaceutical Holdings Group의 현재 배당 수익률은 15.09 %입니다.

Sihuan Pharmaceutical Holdings Group의 배당금은 언제 지급되나요?

Sihuan Pharmaceutical Holdings Group은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Sihuan Pharmaceutical Holdings Group의 배당금은 얼마나 안전한가요?

Sihuan Pharmaceutical Holdings Group은(는) 지난 16년 동안 매년 배당금을 지급했습니다.

Sihuan Pharmaceutical Holdings Group의 배당금은 얼마입니까?

향후 12개월 동안 0.07 CNY의 배당금이 예상됩니다. 이는 배당수익률 14.8 %에 해당합니다.

Sihuan Pharmaceutical Holdings Group이(가) 속해 있는 섹터는 어디인가요?

Sihuan Pharmaceutical Holdings Group은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Sihuan Pharmaceutical Holdings Group kaufen, um die vorherige Dividende zu erhalten?

Sihuan Pharmaceutical Holdings Group의 마지막 배당금을 0.037 CNY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Sihuan Pharmaceutical Holdings Group의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Sihuan Pharmaceutical Holdings Group의 2023년도 배당금은 얼마였습니까?

2023년에 Sihuan Pharmaceutical Holdings Group는 0.118 CNY를 배당금으로 지급했습니다.

Sihuan Pharmaceutical Holdings Group는 어떤 화폐로 배당금을 지급하나요?

Sihuan Pharmaceutical Holdings Group의 배당금은 CNY에 지급됩니다.

Scope 1 - 직접 방출	52,191.66
스코프 2 - 구매한 에너지로부터의 간접적인 배출	71,100.59
Scope 3 - 가치 창출 체인 내의 간접 배출	—
총 CO₂ 배출량	123,292.25
CO₂ 감소 전략	✅
석탄 에너지	❌
원자력	❌
동물 실험	✅
펠츠 & 레더	—
살충제	—
팜 오일	—
담배	❌
유전자 변형 생물체	❌
기후 개념	—
지속 가능한 임업	—
재활용 규정	❌
환경 친화적인 포장	✅
위험물질	✅
연료 소비량과 효율성	❌
물 사용량 및 효율성	✅

여성 직원 비율	57.26
관리 직위에서의 여성 비율	—
아시아 직원 비율	—
아시아 경영진 비율	—
히스패닉/라티노 직원 비율	—
히스패닉/라티노 관리 부문 지분	—
흑인 직원 비율	—
블랙 매니지먼트 지분	—
흰색 종업원의 비율	—
화이트 매니지먼트 지분	—
성인 콘텐츠	❌
알코올	❌
무기	—
총기	❌
도박	❌
군사 계약	❌
인권 개념	✅
개인정보 보호 정책	—
작업 및 건강 보호	✅
카톨릭	✅

환경 보고	✅
이해관계자 참여	✅
콜백 정책	❌
카르텔법	❌

증권거래소	Sihuan Pharmaceutical Holdings Group 티커
프랑크푸르트	TEL1.F
HKSE	0460.HK
뮌헨	TEL1.MU
PNK	SHPHF

Sihuan Pharmaceutical Holdings Group 티커	Sihuan Pharmaceutical Holdings Group FIGI
460:HK	BBG0016NP3X0
TEL1:TH	BBG00186L5D6
TEL1:GR	BBG00189WS02
TEL1:GF	BBG00189WS11
TEL1:GS	BBG00189WS48
TEL1:GM	BBG00189WS57
SHPHF:US	BBG00280F1X1
SHPHF:PQ	BBG00280F2B3
SHPHF:UV	BBG00280F2D1
460:H1	BBG006Z3JG05
460EUR:EO	BBG007BD7210
460EUR:XH	BBG007BD7247
460EUR:XF	BBG007BD7265
460EUR:XE	BBG007BD7283
460EUR:XJ	BBG007BD7292
460EUR:XL	BBG007BD72B9
460EUR:XG	BBG007BD72C8
460EUR:XO	BBG007BD72D7
460EUR:XS	BBG007BD72J1
460EUR:XA	BBG007BD72K9
460EUR:E1	BBG007BD72L8
460EUR:XT	BBG007BD72M7
460EUR:XW	BBG007BD72N6
460EUR:XU	BBG007BD72P4
460EUR:XV	BBG007BD72R2
460EUR:EU	BBG007BD72T0
460:H2	BBG00F134YW4
460EUR:XX	BBG00JN88QH1
460N:PO	BBG00JRFYLR2
460N:L3	BBG00JRG5YR4
460N:B3	BBG00JRG6KT1
460HKD:X2	BBG00JRGQ610
460HKD:XB	BBG00JRGQ629
460HKD:XH	BBG00JRGQ647
460HKD:XF	BBG00JRGQ665
460HKD:XE	BBG00JRGQ683
460HKD:XJ	BBG00JRGQ692
460HKD:XL	BBG00JRGQ6B9
460HKD:XG	BBG00JRGQ6C8
460HKD:XO	BBG00JRGQ6D7
460HKD:XS	BBG00JRGQ6J1
460HKD:XA	BBG00JRGQ6K9
460HKD:E1	BBG00JRGQ6L8
460HKD:XT	BBG00JRGQ6M7
460HKD:XW	BBG00JRGQ6N6
460HKD:XU	BBG00JRGQ6P4
460HKD:XV	BBG00JRGQ6Q3
460HKD:XM	BBG00JRGQ6R2
460HKD:XQ	BBG00JRGQ6T0
460HKD:XX	BBG00JRGQ6V7
460HKD:XZ	BBG00JRGQ6W6
460HKD:EU	BBG00JRGQ6Y4
460N:L1	BBG00Y7B02H0
460JPY:XH	BBG00ZV6XYV9
460JPY:XF	BBG00ZV6XYX7
460JPY:XE	BBG00ZV6XYZ5
460JPY:XL	BBG00ZV6XZ19
460JPY:XG	BBG00ZV6XZ28
460JPY:XO	BBG00ZV6XZ37
460JPY:XA	BBG00ZV6XZ73
460JPY:XT	BBG00ZV6XZ91
460JPY:XW	BBG00ZV6XZB8
460JPY:XU	BBG00ZV6XZC7
460JPY:XV	BBG00ZV6XZF4
460JPY:XM	BBG00ZV6XZG3
460JPY:EU	BBG00ZV6XZP3
TEL1:LA	BBG018H948P4
TEL1:LU	BBG018J2S9K4

2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0.05	0.06	0.1	0.16	0.29	0.51	0.71	1.04	2.24	3.04	2.59	3.08	3.17	3.19	2.75	2.92	2.88	2.46	3.04	2.18	1.86	2.17	2.54	12.85
-	21.57	62.90	59.41	77.64	78.32	38.82	46.33	116.41	35.68	-14.99	19.26	2.69	0.57	-13.81	6.27	-1.34	-14.38	23.30	-28.21	-14.72	16.77	16.90	406.22
52.94	56.45	54.46	77.02	78.67	73.73	73.02	71.81	76.45	75.25	56.26	68.45	70.35	68.70	72.35	81.56	79.53	77.68	79.99	68.18	69.62	-	-	-
0.03	0.04	0.06	0.12	0.23	0.38	0.52	0.74	1.71	2.29	1.46	2.11	2.23	2.19	1.99	2.38	2.29	1.91	2.43	1.49	1.3	0	0	0
0.02	0.03	0.05	0.11	0.17	0.3	0.42	0.62	1	1.02	1.5	1.98	2.07	1.94	1.47	1.72	1.39	0.49	0.68	-0.54	-0.14	-0.77	-0.57	9.51
33.33	41.94	44.55	67.08	60.84	58.82	58.62	59.36	44.47	33.60	57.89	64.17	65.49	60.75	53.37	59.07	48.44	19.68	22.25	-24.58	-7.53	-35.27	-22.61	73.97
0.02	0.02	0.04	0.09	0.18	0.24	0.33	0.52	0.82	0.9	1.28	1.67	2.06	1.71	1.45	1.62	-2.75	0.47	0.42	-1.91	-0.05	0.02	0.1	2.41
-	29.41	72.73	136.84	98.89	32.40	37.55	60.12	57.85	9.71	42.04	30.14	23.40	-17.17	-15.22	11.81	-270.04	-117.18	-12.05	-560.10	-97.18	-142.59	347.83	2,240.78
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0.75	0.75	0.94	0.94	0.9	0.94	7.5	8.01	10.36	10.35	10.35	10.36	10.36	10.14	9.48	9.47	9.47	9.47	9.48	9.33	9.3	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

한 눈에 저평가된 주식을 인식하세요 fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

가격

가격

티커460.HK

ISINBMG8162K1137

WKNA1C72G

Sihuan Pharmaceutical Holdings Group 주식 매출, EBIT, 이익 BMG8162K1137 · A1C72G

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Sihuan Pharmaceutical Holdings Group 매출, 이익 및 EBIT 역사

Sihuan Pharmaceutical Holdings Group 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Sihuan Pharmaceutical Holdings Group 주식 마진 BMG8162K1137 · A1C72G

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Sihuan Pharmaceutical Holdings Group 마진 역사

Sihuan Pharmaceutical Holdings Group 주식 매출, EBIT, 주당 순이익 BMG8162K1137 · A1C72G

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Sihuan Pharmaceutical Holdings Group 매출, 이익 및 EBIT 주당 역사

Sihuan Pharmaceutical Holdings Group 주식 및 주식 분석

Sihuan Pharmaceutical Holdings Group 역사적인 P/E, EBIT 및 P/S에 따른 평가

Sihuan Pharmaceutical Holdings Group 주식 수량 BMG8162K1137 · A1C72G

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Sihuan Pharmaceutical Holdings Group 주식 분할

Sihuan Pharmaceutical Holdings Group 주식 배당금 BMG8162K1137 · A1C72G

배당금

배당금에 대한 개요

해석 및 사용

투자 전략

Sihuan Pharmaceutical Holdings Group 배당금 내역

Sihuan Pharmaceutical Holdings Group 주식 배당률 BMG8162K1137 · A1C72G

배당비율

연간 배당비율이란 무엇인가요?

데이터 해석 방법

투자에 대한 데이터 사용

Sihuan Pharmaceutical Holdings Group 배당금지급률 역사

Sihuan Pharmaceutical Holdings Group 수익 예상

Sihuan Pharmaceutical Holdings Group 수익 놀라움

Eulerpool ESG Scorecard© Sihuan Pharmaceutical Holdings Group 주식을 위해

Eulerpool World ESG Rating (EESG©)

76/ 100

🌱 Environment

👫 Social

🏛️ Governance

환경

소셜 (사회적)

지배구조 (기업 경영)

Sihuan Pharmaceutical Holdings Group 주식 주주 구조

Sihuan Pharmaceutical Holdings Group 임원진 및 경영진

Sihuan Pharmaceutical Holdings Group 공급망

Sihuan Pharmaceutical Holdings Group 주식에 대한 자주 묻는 질문

한 눈에 저평가된 주식을 인식하세요
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

티커
460.HK

ISIN
BMG8162K1137

WKN
A1C72G